United States · 
Who invested in Dynogen Pharmaceuticals?
Dynogen Pharmaceuticals's investors include Atlas Venture, Abingworth, Oxford Bioscience Partners, HealthCare Ventures and Wellcome Trust, and 3 more on record.
20032004
$13MGrowth$50MSeries BUnited States · Series B startup
Who invested in Dynogen Pharmaceuticals
2 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$63Mraised across 2 rounds since 2002, from 2 sources
$13MGrowth$50MSeries B
- Latest round
- Series B, $50MApr 2004
- Step-upi
- 3.8×
- Investors
- 8
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Growth, $13M Nov 2002
- Biggest round
- $50M Series B · Apr 2004
- Between rounds
- 17 months from the last two
The rounds
- Apr 2004Series B$50M5 new
From a historical funding record
- Nov 2002Growth$13M3 new
From a historical funding record
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Oxford Bioscience PartnersGrowth equity1round
HealthCare VenturesGrowth equity1round
Medica Venture PartnersVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Dynogen Pharmaceuticals
How much has Dynogen Pharmaceuticals raised?
Dynogen Pharmaceuticals has raised $63M across 2 rounds since 2002.
When did Dynogen Pharmaceuticals last raise?
Dynogen Pharmaceuticals's most recent round was a Series B of $50M in Apr 2004.
What was Dynogen Pharmaceuticals's biggest round?
Its most recent round, $50M in Apr 2004, is also its largest on record.
Who backed Dynogen Pharmaceuticals first?
Dynogen Pharmaceuticals's first round on record, in Nov 2002, was backed by Oxford Bioscience Partners, HealthCare Ventures and A. M. Pappas & Associates.
What stage is Dynogen Pharmaceuticals at?
Dynogen Pharmaceuticals's latest named round is a Series B, in Apr 2004.
Where is Dynogen Pharmaceuticals based?
Dynogen Pharmaceuticals is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.